No Label Ventures
VC Fund
London, United Kingdom
No Label Ventures is a VC fund in London focused on Artificial Intelligence and Software. An early stage, and very biased, European VC fund.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries No Label Ventures invests in
Stages No Label Ventures invests in
Countries No Label Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $2.1M–$8.6M
- Pre-Seed
- $1M–$8.6M
Investment Focus
Industry
- Artificial Intelligence 7 (44%)
- Software 5 (31%)
- Information Technology 3 (19%)
- FinTech 2 (13%)
- Hospital 2 (13%)
Stage
- Seed 8 (50%)
- Pre-Seed 5 (31%)
- Series A 2 (13%)
- Angel 1 (6%)
Country
- France 6 (38%)
- United Kingdom 5 (31%)
- United States 3 (19%)
- Kazakhstan 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ramzi Rafih
General Partner
|
General Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Shiplong
|
Shiplog is an AI-powered customer intelligence platform designed to boost net revenue retention (NRR) for B2B SaaS, subscription businesses, e-commerce, and consumer apps. Its collaborative AI agent, Ada, turns live customer signals into real-time recommendations and automated workflows, enabling cross-functional teams to automate one-to-oneengagement at scale. | $1M / Pre-Seed / Aug 04, 2026 | |
Uncovr
|
Uncovr is an AI-powered surgical intelligence and documentation platform that automatically transforms operating room videos into structured clinical reports and billing codes. | $7M / Seed / Jun 10, 2026 | |
Zango
|
Zango is an AI-powered compliance automation platform designed to help financial services firms manage regulatory change across multiple regions, including the UK and EU. Leveraging cutting-edge AI, the platform performs real-time horizon scanning, automated gap analysis, and human validation to ensure accuracy and maintain security andtransparency. Backed by industry-leading investors, it empowers compliance teams to dramatically accelerate processes and reduce manual oversight. | $4.8M / Seed / Jul 01, 2025 | |
|
Nia
|
Nia is an AI platform building the next generation of autonomous engineering agents and redefining how developers interact with their codebase. | Pre-Seed / May 07, 2025 | |
Nozomio
|
How do you discover the future of software engineering? We're building it.Language models can write code better than most humans, but they often destroy codebases due to poor context management and understanding. The future isn't about replacing developers - it's about empowering them to orchestrate AI agents effectively.We're creating systems that enable small teams of developers to manage large-scale agent operations across the entire software lifecycle - from development to QA, security audits, and deployment.It's called Nozomio. | $1.5M / Pre-Seed / May 07, 2025 | |
Spore.Bio
|
Spore Biotechnologies is a manufacturing company that develops innovative technological tools to help factories manufacture safe products.Spore Biotechnologies are developing new weapons to fight climate change, globalization, new consuming habits, bacterial resistance, and microbiological scandals.Founded by Amine Raji and Maxime Mistretta in2022 and is located in Paris, France. | $23M / Series A / Feb 20, 2025 | |
Guided Energy
|
Guided Energy is a platform for fleets to charge and operate their electric vehicles. Fleet managers schedule charging sessions, monitor progress, and receive alerts for issues such as charging disruptions. To maximise fleet productivity, our software suggests optimal charging sequences, job allocations and can directly control the power output ofchargers. Integrations across the ecosystem give operators critical visibility and streamline painful workflows from payments to invoice and expense management. | $5.2M / Seed / Feb 06, 2024 | |
|
Spore.Bio
|
Spore Biotechnologies is a manufacturing company that develops innovative technological tools to help factories manufacture safe products.Spore Biotechnologies are developing new weapons to fight climate change, globalization, new consuming habits, bacterial resistance, and microbiological scandals.Founded by Amine Raji and Maxime Mistretta in2022 and is located in Paris, France. | $8.6M / Pre-Seed / Dec 12, 2023 | |
Callyope
|
Callyope is a human-centered technology that can enhance millions of people's lives by increasing the objectivity and responsiveness of brain health monitoring. Callyope develops solutions for remote patient monitoring that assist caregivers in identifying relapses and determining the best course of action. | $2.4M / Seed / Nov 22, 2023 | |
Pangea Bio
|
Pangea Botanica helps to accelerate the discovery and development of therapeutics for patients by using naturally occurring compounds and traditional remedies, while preserving ethnobotanical knowledge and ecosystems. It is a biotechnology research organisation that offers drug discovery and development services. | Series A / Sep 27, 2023 | |
| See all 16 investments → | |||
Co-Investors
LocalGlobe
4 deals together
Better Angle
3 deals together
Nexus Venture Partners
3 deals together
Famille C Participations
2 deals together
Kima Ventures
2 deals together
Seaside Ventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does No Label Ventures invest in?
No Label Ventures invests primarily in Artificial Intelligence, Software and Information Technology startups, most often at Seed and Pre-Seed stage. Most of the 16 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is No Label Ventures's check size?
No Label Ventures typically joins rounds of $2.1M–$8.6M at Seed and $1M–$8.6M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds No Label Ventures participates in.
How do I contact No Label Ventures?
Public channels for No Label Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at No Label Ventures?
The team at No Label Ventures includes Ramzi Rafih (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
